Skip to content

XERIANT, INC.: 10-Q filed 2026-02-17

What XERIANT, INC. reported in its quarterly report filed 2026-02-17 (fiscal Q2 2026): 34 published measures, 105 facts as tagged in accession 0001477932-26-000862.

This filing

Form
10-Q (quarterly report)
Filed
2026-02-17
Fiscal period
fiscal Q2 2026
Accession
0001477932-26-000862 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XERIANT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-12-31103,440USD
At 2025-06-3068,219USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-12-315,740,484USD
At 2025-06-308,768,682USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-12-31-2,759,896USD
At 2025-06-30-5,823,315USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-297,593USD92
2025-07-01 to 2025-12-311,928,479USD184
2025-07-01 to 2025-09-302,226,072USD92
2024-10-01 to 2024-12-31-417,269USD92
2024-07-01 to 2024-12-31-789,491USD184
2024-07-01 to 2024-09-30-372,222USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-07-01 to 2025-12-31-383,317USD184
2024-07-01 to 2024-12-31-750,922USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-07-01 to 2025-12-31415,000USD184
2024-07-01 to 2024-12-31352,000USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-07-01 to 2025-12-310USD184
2024-07-01 to 2024-12-310USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-12-31-26,410,127USD
At 2025-06-30-28,338,606USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-10-01 to 2025-12-31779,770,035shares92
2025-07-01 to 2025-12-31752,961,770shares184
2024-10-01 to 2024-12-31596,196,491shares92
2024-07-01 to 2024-12-31571,876,754shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-10-01 to 2025-12-31779,770,035shares92
2025-07-01 to 2025-12-311,701,389,294shares184
2024-10-01 to 2024-12-31596,196,491shares92
2024-07-01 to 2024-12-31571,876,754shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-10-01 to 2025-12-310USD/shares92
2025-07-01 to 2025-12-310USD/shares184
2024-10-01 to 2024-12-310USD/shares92
2024-07-01 to 2024-12-310USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-10-01 to 2025-12-310USD/shares92
2025-07-01 to 2025-12-310USD/shares184
2024-10-01 to 2024-12-310USD/shares92
2024-07-01 to 2024-12-310USD/shares184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-15,928USD92
2025-07-01 to 2025-12-31108,657USD184
2024-10-01 to 2024-12-310USD92
2024-07-01 to 2024-12-310USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-12-313,228USD
At 2025-06-304,158USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-10-01 to 2025-12-3135,000USD92
2025-07-01 to 2025-12-3194,500USD184
2024-10-01 to 2024-12-3114,505USD92
2024-07-01 to 2024-12-31284,006USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-231,062USD92
2025-07-01 to 2025-12-31-535,137USD184
2024-10-01 to 2024-12-31-335,583USD92
2024-07-01 to 2024-12-31-694,378USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-12-3194,916USD
At 2025-06-3056,677USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2025-10-01 to 2025-12-3135,822USD92
2025-07-01 to 2025-12-3180,605USD184
2024-10-01 to 2024-12-3151,379USD92
2024-07-01 to 2024-12-31112,996USD184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-12-315,739,976USD
At 2025-06-308,765,577USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-10-01 to 2025-12-31231,062USD92
2025-07-01 to 2025-12-31535,137USD184
2024-10-01 to 2024-12-31335,583USD92
2024-07-01 to 2024-12-31694,378USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-10-01 to 2025-12-3116,303USD92
2025-07-01 to 2025-12-3170,269USD184
2024-10-01 to 2024-12-3115USD92
2024-07-01 to 2024-12-3126,576USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-12-31862,763,035shares
At 2025-06-30695,746,625shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-12-3176,533USD
At 2025-06-3044,850USD
At 2024-12-31254,195USD
At 2024-06-30653,117USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-12-3123,543,686USD
At 2025-06-3022,410,416USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-12-31-5,637,044USD
At 2025-09-30-5,702,498USD
At 2025-06-30-8,700,463USD
At 2024-12-31-8,689,477USD
At 2024-09-30-8,497,663USD
At 2024-06-30-8,612,454USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-12-315,296USD
At 2025-06-307,384USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-12-315,296USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-313,521USD92
2025-07-01 to 2025-12-312,037,136USD184
2024-10-01 to 2024-12-31-417,269USD92
2024-07-01 to 2024-12-31-789,491USD184

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-07-01 to 2025-12-311,928,479USD184
2024-07-01 to 2024-12-31-789,491USD184

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-297,593USD92
2025-07-01 to 2025-12-311,928,479USD184
2024-10-01 to 2024-12-31-410,050USD92
2024-07-01 to 2024-12-31-774,896USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-10-01 to 2025-12-3128,381USD92
2025-07-01 to 2025-12-3153,293USD184
2024-10-01 to 2024-12-31145,621USD92
2024-07-01 to 2024-12-31202,066USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-10-01 to 2025-12-31-82,459USD92
2025-07-01 to 2025-12-312,572,273USD184
2024-10-01 to 2024-12-31-81,686USD92
2024-07-01 to 2024-12-31-95,113USD184

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-07-01 to 2025-12-310USD184
2024-07-01 to 2024-12-310USD184

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-07-01 to 2025-12-310USD184
2024-07-01 to 2024-12-310USD184

Inspect the source

Entity
XERIANT, INC. / CIK 0001481504
Captured
2026-09-20T09:08:58.811Z
SEC response SHA-256
24601b8f9caaca687cd26a472196c97b42ac498ab622839dc0af56c4e7e8b865

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001481504.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))